NCT00752869View on ClinicalTrials.gov

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Hypogonadism

Interventions

DRUG

dutasteride

0.5mg by mouth one time per day for 1 year

DRUG

placebo

one tablet per day for 1 year

Trial Locations (2)

002445

Men's Health Boston, Boston

02906

The Miriam Hospital, Providence

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

The Miriam Hospital

OTHER